When was Nucro-Technics founded?

Nucro-Technics was founded in 1970 and raised its 1st funding round 49 years after it was founded.

Where is Nucro-Technics located?

Nucro-Technics is headquartered in Scarborough, Canada.

Who is the current CEO of Nucro-Technics?

John Fanaras of Nucro-Technics.

How many employees does Nucro-Technics have?

As of Jun 30, 2026, the latest employee count at Nucro-Technics is 94.

Is Nucro-Technics a funded company?

Nucro-Technics is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Jul 09, 2019.

When was the latest funding round of Nucro-Technics?

Nucro-Technics' latest funding was a $***** Grant (prize money) round on Jul 09, 2019, with participation from 0 investor.

Where does Nucro-Technics rank among its competitors?

Nucro-Technics ranks 6th amongst 341 active competitors, of which 15 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Dash Bio, which secured $11M in Jun, 2025.

Who are the top competitors of Nucro-Technics?

Nucro-Technics' top competitors include Solvias, BioAgilytix and Advion. Among them, Dash Bio secured the most recent funding round in June, 2025.

Nucro-Technics - 2026 Company Profile, Team, Funding & Competitors

Nucro-Technics is an acquired company based in Scarborough (Canada), founded in 1970. It operates as a Full-service bioanalytical CRO offering toxicity, bioanalytical and stability study services. Nucro-Technics has raised an undisclosed amount in funding. The company has 341 active competitors, including 15 funded and 86 that have exited. Its top competitors include companies like Solvias, BioAgilytix and Advion.

Company Details

Nucro-Technics is a CRO offering a suite of bioanalytical and laboratory services for preclinical and clinical development of drugs for the pharma and biotech industries. The company provides contract R&D, logistics, QC and QA services to the pharmaceutical, biotechnology and the medical device industries. Their service portfolio includes analytical chemistry, bioassay studies, toxicology (including genetic toxicology) studies, Bioanalytical Services, microbiology and stability testing services, regulatory support. They also offer their services for the development of medical devices and natural health products.

Website: www.nucro-technics.com/
Phone Number: +1 **********

Key Metrics

Founded Year

1970

Location

Scarborough, Canada

Stage

Acquired

Latest Funding Round

Grant (prize money), Jul 09, 2019, $*****

Ranked

6^th among 341 active competitors

Employee Count

94 as on Jun 30, 2026

Similar Companies

Solvias & 374 more

Exit Details

Acquired by Frontage Laboratories (Aug 16, 2023)

View Nucro-Technics' full profile

Nucro-Technics got acquired by Frontage Laboratories on Aug 16, 2023.

Click here to take a look at Nucro-Technics's acquisition in detail

Nucro-Technics has raised funding over 1 round.

Here is the list of recent funding rounds of Nucro-Technics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 09, 2019	7311327	Grant (prize money)	8990048	8799459	8282813	1923773

Access funding benchmarks and valuations. Sign up today!

View details of Nucro-Technics's funding rounds and investors

Nucro-Technics' employee count trend

Nucro-Technics has 94 employees as of Jun 26. Here is Nucro-Technics's employee count trend over the years:

Uncover Nucro-Technics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nucro-Technics include Solvias, BioAgilytix and Advion. Here is the list of Top 10 competitors of Nucro-Technics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Solvias 1999, Kaiseraugst (Switzerland), Acquired	Developer and manufacturer of medical devices, cosmetics, agrochemicals, and chemicals	-	Water Street, Broadoak Capital Partners & 1 others	59/100
2nd	BioAgilytix 2008, Durham (United States), Acquired	Global bioanalytical services leader, supporting drug development across various modalities	-	GHO Capital Partners, Caledonia Private Capital ... & 2 others	57/100
3rd	Advion 1993, Ithaca (United States), Acquired	Mass spectrometry, chromatography, and purification solutions for scientific advancement	$45.6M	Gefinor Capital, Aisling Capital & 3 others	50/100
4th	Dash Bio 2024, Boston (United States), Series A	Provider of automated bioanalysis platform for accelerated clinical drug development	$17.5M	The Aligned Fund, Freestyle & 5 others	48/100
5th	ImmunXperts 2014, Charleroi (Belgium), Acquired	CRO specializing in human immune system based bioassay development services	$1M	Biowin, Sambrinvest	48/100
6th	Nucro-Technics 1970, Scarborough (Canada), Acquired	Full-service bioanalytical CRO offering toxicity, bioanalytical and stability study services	-	-	47/100
7th	Teena Biolabs 1999, Hyderabad (India), Acquired	Testing laboratory offering pharmacopeial tests, calibration & validation services	-	-	46/100
8th	Evans Analytical Group 1978, San Diego (United States), Acquired	Materials testing and engineering sciences, accelerating innovation through multidisciplinary expertise	-	Odyssey Investment Partners, Riverside & 1 others	46/100
9th	Nordic Bioscience 1996, Herlev (Denmark), Late Stage	Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform	-	KKR, Europa	46/100
10th	Sitec Labs 2004, Mumbai (India), Unfunded	CRO offering bioequivalence and bioanalytical services	-	-	45/100